Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-034447
Filing Date
2026-03-26
Accepted
2026-03-26 10:05:04
Documents
85
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0282586-20f_canfite.htm   iXBRL 20-F 2072052
2 AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF CAN-FITE BIOPHARMA LTD ea028258601ex1-1.htm EX-1.1 258400
3 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 ea028258601ex2-1.htm EX-2.1 62431
4 CERTIFICATION ea028258601ex12-1.htm EX-12.1 10093
5 CERTIFICATION ea028258601ex13-1.htm EX-13.1 3816
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea028258601ex15-1.htm EX-15.1 6473
7 GRAPHIC ea028258601_img1.jpg GRAPHIC 110496
8 GRAPHIC ea028258601_img2.jpg GRAPHIC 36435
9 GRAPHIC ea028258601_img3.jpg GRAPHIC 50281
10 GRAPHIC ea028258601_img4.jpg GRAPHIC 89642
11 GRAPHIC ea028258601_img5.jpg GRAPHIC 53232
12 GRAPHIC ea028258601_img6.jpg GRAPHIC 65474
13 GRAPHIC ea028258601_img7.jpg GRAPHIC 4984
  Complete submission text file 0001213900-26-034447.txt   8475531

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE canf-20251231.xsd EX-101.SCH 52939
15 XBRL CALCULATION FILE canf-20251231_cal.xml EX-101.CAL 32085
16 XBRL DEFINITION FILE canf-20251231_def.xml EX-101.DEF 184231
17 XBRL LABEL FILE canf-20251231_lab.xml EX-101.LAB 425978
18 XBRL PRESENTATION FILE canf-20251231_pre.xml EX-101.PRE 329367
89 EXTRACTED XBRL INSTANCE DOCUMENT ea0282586-20f_canfite_htm.xml XML 692327
Mailing Address 26 BEN GURION STREET RAMAT GAN L3 5257346
Business Address 26 BEN GURION STREET RAMAT GAN L3 5257346 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36203 | Film No.: 26794802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)